We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The Medicines and Healthcare products Regulatory Agency (MHRA) approved a maximum dose of up to 7.2mg per week of semaglutide (Wegovy) on 6 January 2026.
Millions of Brits could boost their mood by spending 5 minutes taking a Healthy Choices Quiz launched by the government and the NHS.
Milestone deal secures UK’s medicines access for patients, with a wide range of groundbreaking new treatments to reach NHS front-line quicker.
Summary of the latest safety advice for medicines and medical device users
Patients living with rare blood disorders to benefit from increased access to treatment and availability of services, thanks to £9 million investment.
A programme to improve UK workforce readiness by upskilling 10 million UK workers in AI skills by 2030.
Better care for patients living with myalgic encephalomyelitis/chronic fatigue syndrome, with plans to invest in research and offer care closer to home.
This measure is about increasing the Vehicle Excise Duty expensive car supplement threshold for zero-emission cars to £50,000.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).